BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Walter F, Nierer L, Rottler M, Duque AS, Weingandt H, Well J, Shpani R, Landry G, Seidensticker M, Streitparth F, Ricke J, Belka C, Corradini S. Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma. Radiat Oncol 2021;16:86. [PMID: 33957941 DOI: 10.1186/s13014-021-01812-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Luerken L, Haimerl M, Doppler M, Uller W, Beyer LP, Stroszczynski C, Einspieler I. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma. Rofo 2022. [PMID: 35545102 DOI: 10.1055/a-1768-0954] [Reference Citation Analysis]
2 Nguyen AT, Atkins KM, Kamrava M. In Regard to Apisarnthanarax et al. Pract Radiat Oncol 2022;12:e239. [PMID: 35512991 DOI: 10.1016/j.prro.2021.12.013] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Scafa D, Muedder T, Holz JA, Koch D, Nour Y, Garbe S, Gonzalez-Carmona MA, Feldmann G, Vilz TO, Köksal M, Giordano FA, Schmeel LC, Sarria GR. Dosimetric Comparison of Intraoperative Radiotherapy and SRS for Liver Metastases. Front Oncol 2021;11:767468. [PMID: 34926271 DOI: 10.3389/fonc.2021.767468] [Reference Citation Analysis]
4 Walter F, Rottler M, Nierer L, Landry G, Well J, Rogowski P, Mohnike K, Seidensticker M, Ricke J, Belka C, Corradini S. Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients. Cancers (Basel) 2021;13:6250. [PMID: 34944869 DOI: 10.3390/cancers13246250] [Reference Citation Analysis]
5 Major T, Fröhlich G, Ágoston P, Polgár C, Takácsi-Nagy Z. The value of brachytherapy in the age of advanced external beam radiotherapy: a review of the literature in terms of dosimetry. Strahlenther Onkol 2021. [PMID: 34724086 DOI: 10.1007/s00066-021-01867-1] [Reference Citation Analysis]